home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

October 28, 2024

From Merck & Co., Inc.

Via Business Wire

Large-Cap Stocks In Trouble - Sunday, Oct. 27 ↗

October 27, 2024

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Moderna Named a Top Employer by Science for Tenth Consecutive Year

October 24, 2024

Via ACCESSWIRE

Moderna Unusual Options Activity For October 22 ↗

October 22, 2024

Via Benzinga

A Closer Look at Moderna's Options Market Dynamics ↗

October 21, 2024

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today ↗

October 15, 2024

Via Benzinga

Unveiling 18 Analyst Insights On Moderna ↗

October 15, 2024

Via Benzinga

How Bad Is This News for Novavax? ↗

October 19, 2024

Novavax stock fell 20% in one trading session on the news.

Via The Motley Fool

Large-Cap Stocks In Trouble - Saturday, Oct. 19 ↗

October 19, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Benzinga Bulls And Bears: Apple, Tesla, Netflix, Oklo — And Dogecoin, Meme Coins Outpace Corporate Giants ↗

October 19, 2024

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Via Benzinga

Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season ↗

October 18, 2024

Goldman Sachs identified 20 stocks with high short interest that could be primed for a short squeeze. Hint: A pet retailer tops the chart.

Via Benzinga

(MRNA) - Analyzing Moderna's Short Interest ↗

October 08, 2024

Via Benzinga

Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

October 17, 2024

S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05.

Via Benzinga

Topics Stocks

Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology ↗

October 17, 2024

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.

Via Benzinga

Topics Lawsuit

Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

October 17, 2024

Via ACCESSWIRE

Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock ↗

October 16, 2024

On Wednesday, Cathie Wood’s Ark Invest made significant trades involving Block Inc (NYSE:SQ) and Moderna Inc (NASDAQ:MRNA). The SQ Trade

Via Benzinga

Cathie Wood's Ark Offloads $1.28M In Jack Dorsey's Block Shares Despite Bitcoin Rally ↗

October 15, 2024

On Tuesday, Cathie Wood-led Ark Invest made significant trades, most notably selling off shares of Block Inc. (NYSE:SQ). The SQ Trade

Via Benzinga

GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement ↗

October 15, 2024

GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks royalties for Moderna's alleged unlicensed use of its groundbreaking vaccine...

Via Benzinga

Topics Intellectual Property Lawsuit

The Bull's Biggest Hits And Misses ↗

October 14, 2024

The bull market turned two years old over the weekend. Here are some of the S&P 500's biggest winners and losers over the last two years.

Via Talk Markets

Topics Stocks

Large-Cap Stocks In Trouble - Sunday, Oct. 13 ↗

October 13, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

2 Biotech Stocks That Are Screaming Buys This Month ↗

October 12, 2024

They won't remain southbound forever.

Via The Motley Fool

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table ↗

October 10, 2024

On Thursday Oct 10, 2024 Cathie Wood-Led Ark Invest sold over $9 million worth of Moderna stock.

Via Benzinga

Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer ↗

October 10, 2024

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could...

Via Benzinga

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 08, 2024

From The Schall Law Firm

Via Business Wire

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

October 08, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 07, 2024

Via Benzinga

Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio? ↗

October 06, 2024

Eleven large-cap stocks were worst performers last week. Decline in Stars performance and sales, regulations and supply issues caused the drop.

Via Benzinga

MRNA Deadline: Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights

October 05, 2024

From Rosen Law Firm

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

October 04, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer ↗

October 04, 2024

Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.

Via Investor's Business Daily

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com